NYSE: PMPhilip Morris International Inc Stock
$91.41-1.17 (-1.26%)
Updated Oct 2, 2023
PM Price
$91.41
Fair Value Price
N/A
Market Cap
$141.90B
52 Week Low
$84.00
52 Week High
$105.62
P/E
17.68x
P/B
-14.62x
P/S
2.19x
PEG
2.49x
Dividend Yield
5.59%
Revenue
$69.20B
Earnings
$8.05B
Gross Margin
30%
Operating Margin
15.75%
Profit Margin
11.6%
Debt to Equity
-7.2
Operating Cash Flow
$9B
Beta
0.69
Next Earnings
Oct 19, 2023
Ex-Dividend
Sep 26, 2023
Next Dividend
Oct 12, 2023
PM Overview
Philip Morris International Inc. a tobacco company that is evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. Its current product portfolio includes cigarettes and smoke-free products, including heat-not-burn, vapor and oral nicotine products sold in markets outside the U.S. Its cigarette brands include Marlboro, Bond Street, Chesterfield, L&M, Lark, and Philip Morris. PMI was incorporated in 1987 and is headquartered in New York, NY.
Zen Score
–
Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PM scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
PM ($91.41) is trading above its intrinsic value of $36.12, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
PM is poor value based on its earnings relative to its share price (17.68x), compared to the US market average (12.38x)
P/E vs Market Valuation
PM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more PM due diligence checks available for Premium users.
Be the first to know about important PM news, forecast changes, insider trades & much more!
PM News
Valuation
PM price to earnings (PE)
For valuing profitable companies with steady earnings
Company
17.68x
Industry
12.98x
Market
12.38x
PM is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
PM is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
PM price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-14.62x
Industry
3.66x
PM price to earnings growth (PEG)
For valuing profitable companies with growth potential
PM is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
PM's financial health
Profit margin
Revenue
$9.0B
Net Income
$1.6B
Profit Margin
17.5%
PM's Earnings (EBIT) of $10.90B... subscribe to Premium to read more.
Interest Coverage Financials
PM's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$61.9B
Liabilities
$69.8B
Debt to equity
-7.2
PM's short-term liabilities ($23.25B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
PM's long-term liabilities ($46.58B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
PM's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
PM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$3.4B
Investing
-$483.0M
Financing
-$1.8B
PM's operating cash flow ($8.65B)... subscribe to Premium to read more.
Debt Coverage Financials
PM vs Tobacco Stocks
Philip Morris International Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.